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Abstract
Clinical and experimental evidence suggests that obesity-associated inflammation increases disease activity during colitis,
attributed in part to the effects of Th17 cells. Using a model of concurrent obesity and colitis, we monitored changes in
critical immune cell subsets and inflammatory biomarker expression in three key tissues: visceral adipose tissue, colon (local
inflammatory site) and spleen (systemic inflammatory site), and we hypothesized that n-3 PUFA would reduce the
percentage of inflammatory immune cell subsets and suppress inflammatory gene expression, thereby improving the
disease phenotype. Obesity was induced in C57BL/6 mice by feeding a high fat (HF) diet (59.2% kcal) alone or an isocaloric
HF diet supplemented with fish oil (HF-FO) for 12 weeks. Colitis was induced via a 2.5% trinitrobenzene sulfonic acid (TNBS)
enema. The HF-FO diet improved the obese phenotype by reducing i) serum hormone concentrations (leptin and resistin),
ii) adipose tissue mRNA expression of inflammatory cytokines (MCP-1, IFNc, IL-6, IL17F and IL-21) and iii) total (F4/80+
CD11b+) and inflammatory adipose tissue M1 (F4/80+ CD11c+) macrophage content compared to HF (P,0.05). In addition,
the HF-FO diet reduced both colitis-associated disease severity and colonic mRNA expression of the Th17 cell master
transcription factor (RORct) and critical cytokines (IL-6, IL-17A, IL-17F, IL-21, IL-23 and IFNc) versus HF (P,0.05). Compared to
HF, the percentage of both splenic Th17 and Th1 cells were reduced by the HF-FO group (P,0.05). Under ex vivo polarizing
conditions, the percentage of HF-FO derived CD4+ T cells that reached Th17 cell effector status was suppressed (P= 0.05).
Collectively, these results indicate that n-3 PUFA suppress Th1/Th17 cells and inflammatory macrophage subsets and
reconfigure the inflammatory gene expression profile in diverse tissue sites in obese mice following the induction of colitis.
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Introduction
In the United States the prevalence of obesity is reported to be
approximately 35% among adults [1]. Obesity is associated with
low-grade chronic inflammation occurring within the adipose
tissue and changes in immune cell populations give rise to altered
inflammatory adipokine and cytokine profiles which, in part,
induce skeletal muscle and hepatic insulin resistance, thereby
causally linking obesity and type-2 diabetes [2,3]. Interestingly, fish
oil (FO) derived long chain n-3 polyunsaturated fatty acids
(PUFA), specifically eicosapentaenoic acid (EPA) and docosahex-
aenoic acid (DHA), have been shown to favorably impact obesity-
associated pathologies, including adipose tissue inflammation,
insulin resistance, lipid metabolism and hepatic steatosis
[4,5,6,7,8,9,10,11,12]. Additionally, supplementation of n-3 PUFA
in models of high fat diet-induced obesity results in reduced insulin
[4,6] and leptin [6] levels, and increased adiponectin levels
[5,6,12].
It is estimated that 50% of inflammatory bowel disease (IBD)
subjects utilize self-prescribed complementary alternative medi-
cines/diets, such as FO [13], whose anti-inflammatory effects have
been shown to enhance remission of chronic intestinal inflamma-
tion [14]. In IBD, activation of two inflammatory mucosal CD4+
T cell subsets, Th1 and Th17 cells, plays a central role in the
induction and persistence of chronic inflammation
[15,16,17,18,19,20], and antagonism of the Th17 cell pathway is
associated with reduced disease severity [21,22]. n-3 PUFA have
been shown to antagonize the Th1 subset [23,24] and reduce
disease severity in dextran sodium sulfate (DSS)-induced colitis,
while concomitantly suppressing systemic (splenic) and local (colon
lamina propria) Th17 cell accumulation, in part, by decreasing
mucosal expression of critical Th17 cell-related cytokines [25].
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In obesity, mesenteric adipose tissue-derived inflammatory
mediators contribute to ongoing intestinal inflammation [26,27].
In Crohn’s disease (CD), mesenteric obesity is implicated in the
disease pathogenesis, wherein fat wrapping and mesenteric
adipose tissue hyperplasia are long established and consistent
features in surgical specimens [27,28,29,30]. There is significant
intra-abdominal fat accumulation (i.e., creeping fat) in CD patients
[31], and histological analysis has revealed abnormalities in the
mesenteric adipose tissue, including pronounced immune cell
infiltration, fibrosis, perivascular inflammation and vessel thicken-
ing [28,29,30]. Ultimately, the hypertrophied mesenteric adipose
that surrounds the intestine [29] contributes actively to disease
severity by increasing the inflammatory milieu comprised of
cytokines (i.e., IL-6), chemokines (MCP-1) and immunomodula-
tory hormones (i.e., leptin and resistin) which may sustain or
perpetuate inflammatory responses in CD patients [26,32,33].
Moreover, the increased visceral adipose mass in obese CD
patients may predispose them to a more aggressive clinical course
[31,34]. For example, disease severity was increased in obese CD
patients, making them more prone to develop active disease (e.g.,
anorectal complications such as anoperineal abscesses or fistulas)
and require hospitalization as compared to non-obese CD patients
[27,31,35]. In animal models, co-morbid diet-induced obesity and
trinitrobenzene sulfonic acid (TNBS)-induced colitis has been
associated with activation of the inflammatory Th17 cell subset,
resulting in more severe colonic histological damage and increased
in vitro production of IL-17 [36]. Since n-3 PUFA antagonize
Th17 cells during DSS-induced colitis [25], we hypothesized that
in a combinatory model of diet-induced obesity and TNBS-
induced colitis, dietary FO would have a beneficial impact on the
overall disease phenotype, in part, by suppressing (local) colonic
Th17 cell polarizing cytokines and by reducing inflammatory T
cell subsets systemically. Therefore, in this study, we monitored
changes in critical immune cell subsets and inflammatory
biomarker (cytokine/adipokine) expression in three key tissues:
visceral adipose tissue, which increases in mass during obesity and
surrounds the inflamed gastrointestinal tract [26,37], the colon
(local site of colitis-induced inflammation) and the spleen (systemic
site of inflammation). Overall, supplementation of n-3 PUFA
during concurrent obesity and TNBS-induced colitis improved
disease outcomes and suppressed both inflammatory immune cell
populations locally and systemically while concomitantly recon-
figuring the inflammatory gene expression profile in multiple tissue
sites.
Materials and Methods
Ethics Statement
All procedures adhered to U.S. Public Health Service Policy
and were approved by the Institutional Animal Care and Use
Committee at Texas A&M University.
Animals and Diet
Specific pathogen-free male C57BL/6 mice were maintained
under barrier conditions for 12 weeks and fed one of two isocaloric
high fat diets (59.2% kcal) which contained an equal amount of
lard (39% kcal) but differing levels of n-3 and n-6 PUFA from
vacuum-deodorized menhaden fish oil (FO) and corn oil (CO),
respectively [high fat (HF): 20.2% kcal corn oil (CO) or high
fat+fish oil (HF-FO): 14.2% kcal FO+6% kcal CO]. Control mice
consumed a low fat (LF) diet (10.4% kcal) [LF: 4.6% kcal
lard+5.8% kcal CO]. The content of bioactive n-3 PUFA in the
HF-FO supplemented diet was 3.6% kcal as DHA and EPA
combined, which is consistent with the level consumed by the
Greenland Inuit [38]. The diets were modeled after the
commercially available high fat and low fat formulations that
have been used elsewhere to produce diet-induced obesity [39,40].
The diet composition is described in Table S1. Diets were
replaced daily to prevent oxidation.
Colitis Induction and Histological Scoring
Colon inflammation was induced by exposure to 2,4,6-trinitro
benzene sulfonic acid (TNBS; Sigma Aldrich) as described
previously [41]. In brief, mice were individually housed and
100 ml of a 1% (w/v) pre-sensitizing dosage of TNBS in the vehicle
[4:1 volume ratio of acetone and olive oil (Azienda)] was applied
topically onto a shaved 1.561.5 cm field between the shoulders.
The site was selected to prevent the animals from ingesting the
TNBS which could induce oral tolerance [41]. After 7 d, mice
were anesthetized with isoflurane to effect and were under
anesthesia for #5 min during which time a 100 ml enema
containing 2.5% (w/v) TNBS in a 1:1 volume ratio of water and
absolute ethanol was administered. To minimize excretion of the
TNBS solution, animals were inverted for 1 min following
completion of the enema and placed head down at a 60u incline
for approximately 5 min. Vehicle control mice were exposed to
the presensitization vehicle topically, followed by an enema
consisting of 1:1 volume ratio of water and absolute ethanol. All
mice were sacrificed 3 d post-enema. Body weights and food
intakes were monitored throughout the study. Mice were sacrificed
by CO2 asphyxiation and colons were excised (distal to the cecum
and proximal to the anus), flushed with sterile PBS and the mucosa
was scraped from one longitudinal half. The other half of the colon
was fixed in 4% paraformaldehyde, swiss-rolled, paraffin embed-
ded and stained with hematoxylin and eosin. The degree of colon
inflammation (score 0–3) and injury (score 0–3) were graded and
combined for a total score in a blinded manner by a board-
certified pathologist (B. Weeks) in accordance with the criteria
outlined previously [25,42].
Serum Hormone Profiles
Orbital plexus blood was collected prior to sacrifice, allowed to
clot at room temperature for 30–45 min, then centrifuged at
140006g for 4 min and the resulting serum was stored at 280uC.
Serum levels of insulin, leptin, resistin and adiponectin were
measured using the Milliplex MAP mouse metabolic hormone
magnetic bead panel (EMD Millipore) and samples were run on
the Bio-Plex 200 System using Bio-Plex Manager 6.0 software
(BioRad).
Isolation of Adipose Tissue and Stromal Vascular Cells
Adipose tissue was isolated and weighed from three individual
fat pads (mesenteric, epididymal and perinephric), which com-
bined represent total visceral adipose. Stromal vascular cells (SVC)
were isolated by collagenase digestion as described previously [43].
Antibodies used in the subsequent SVC flow cytometry analysis
were APC-F4/80 (clone: Bm8, eBioscience), PE-CD11b and APC-
CD11b (clone: M1/70, eBioscience), PE-CD11c (clone: HL3, BD
Biosciences), APC-CD206 (clone: C068C2, BioLegend). M1 and
M2 macrophages were defined as F4/80+ CD11c+ and F4/80+
CD206+, respectively [44,45].
Flow Cytometry Analysis of Treg, Th1 and Th17 Cells
Splenic mononuclear cells were isolated as described [46] and
surface and intracellular staining performed as reported previously
[25]. Cells were preincubated with a FccR blocking monoclonal
mAb (1 mg/mL) (2.4G2, BD Pharmingen) for 10 min on ice,
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followed by surface (CD4) and intracellular (FOXP3, IL-17A or
IFNc) staining. Antibodies used were APC-anti-CD4 (L3T4), PE-
anti-FOXP3 (FJK-16s) (eBioscience), PE-anti-IL-17A (TC11-
18H10) and PE-anti-IFNc (XMG1.2) (BD Pharmingen). Flow
cytometric analysis was conducted using an Accuri C6 flow
cytometer (Accuri Cytometers).
Splenic T Cell in vitro Polarization Conditions
Spleens were removed aseptically and CD4+ T cells were
isolated by positive selection using magnetic CD4 (L3T4)
microbeads according to the manufacturer’s instructions (Miltenyi
Biotec). Cell purity exceeded 90% as described previously [47].
26105 viable CD4+ T cells (assessed via trypan blue exclusion)
were added to each well of a round bottom 96-well plate (BD
Bioscience) in a final volume of 200 ml of complete RPMI [RPMI
1640 medium with 25 mmol/L HEPES (Irvine Scientific), 50 mM
2-mercaptoethanol (Sigma Aldrich), 5% fetal bovine serum (Irvine
Scientific), 2 mM GlutaMAX (Gibco), penicillin 100 U/mL and
streptomycin 0.1 mg/mL (Gibco), henceforth ‘‘complete medi-
um’’]. All cultures were stimulated with 5 mg/ml of plate-bound
anti-CD3 (145-2C11, BD Bioscience) plus 5 mg/ml of soluble anti-
CD28 (37.51, eBioscience). For Treg polarizing conditions,
cultures were supplemented with 2 ng/ml TGF- b1 (BioLegend).
For Th17 cell polarizing conditions, cultures were supplemented
with 2 ng/ml TGF-b1, 10 ng/ml IL-6, 20 ng/ml IL-23 (BioLe-
gend), 10 mg/ml anti-IFNc (AN-18, eBioscience) and 10 mg/ml
anti-IL-4 (11B11, eBioscience). Cells were incubated at 37uC for
72 h and subsequently stimulated with 1X brefeldin A (diluted
from a 10X stock, eBioscience), 1 mM ionomycin (EMD Chem-
icals) and 50 ng/ml PMA (Sigma Aldrich) for an additional 5
hours prior to intracellular staining with PE-anti-FOXP3 (FJK-
16s) (eBioscience) or PE-anti-IL-17A (TC11-18H10) (BD Phar-
mingen) antibodies.
RNA Isolation and Measurement of mRNA Expression
RNA was isolated from vehicle control and TNBS-treated mice
using the RNA 4-PCR kit (Ambion) for colon mucosa scrapings
and the ToTALLY RNA kit (Ambion) for adipose tissue. Real-
time RT-PCR was used to quantify mRNA expression and
amplification was performed using the Taqman Universal PCR
master mix (Applied Biosystems). Taqman gene expression kits
(Applied Biosystems) were used for amplification, namely IL-1b
(Mm00434228_m1), IL-6 (Mm00446190_m1), IL-17A
(Mm00439618_m1), IL-17F (Mm00521423_m1), IL-21
(Mm00517640_m1), IL-23 (Mm00518984_m1), IFNc
(Mm01168134_m1), IL-27 (Mm00461162_m1), TNFa
(Mm00443260_g1), CCL2 (MCP-1, Mm00441242_m1), IL-10
(Mm00439614_m1), TGFb1 (Mm01178820_m1), Rorc (RORct,
Mm01261022_m1), Tbx21 (T-bet, Mm00450960_m1), FOXP3
(Mm00475162_m1). Amplification of mRNA (fluorescence) was
recorded over 40 cycles and the corresponding cycle numbers (Ct)
were used to calculate mRNA expression according to the
calculation: 2(402Ct). Target gene expression was normalized to
ribosomal 18S expression (Mm03928990_g1).
Statistics
The predetermined upper limit of probability for statistical
significance throughout this investigation was P,0.05, and
analyses were conducted using the SAS system (SAS Institute)
for Windows (version 9.0). Data were subjected to two-way
ANOVA (main effects: diet and treatment) followed, if justified, by
testing using Least Squares Means. Data sets not exhibiting a
normal distribution were subjected to the Kruskal-Wallis test (x2
approximation) followed, if justified, by the statistical probability
outcome (P,0.05) using Wilcoxon two-sample testing.
Results
HF Diet Induces an Obese Phenotype which is
Ameliorated by n-3 PUFA Supplementation
Body weights were monitored throughout the study and did not
differ between mice consuming the HF and HF-FO diets
(P.0.05); however, during weeks 6–12 of dietary intervention,
both HF and HF-FO-fed mice gained more weight compared to
LF-fed animals (P,0.05) (Figure 1A). Food intake did not differ
between the HF and HF-FO groups at any point throughout the
duration of the study (P.0.05). During the TNBS pre-sensitization
period (week 11) and following TNBS enemas (week 12), all
dietary groups experienced a modest degree of weight loss that is
typically associated with TNBS treatment [48]. Analysis of visceral
adipose tissue weights (Figure 1B) revealed that compared to HF-
FO mice, the HF diet group exhibited higher perinephric and
mesenteric adipose tissue weights. As expected, adipose tissue
weights in both high fat diets (HF and HF-FO) were elevated
relative to LF (P,0.05). Conversely, there was no difference in
epididymal adipose weights between HF and HF-FO-fed mice
(P=0.25). Interestingly, LF-fed animals had a modestly higher
epididymal fat content (P,0.05); however, elevated or unchanged
epididymal fat weights have been reported previously in low fat
diet fed rodents [9,11]. Overall, combined visceral adipose tissue
mass (mesenteric, perinephric and epididymal) was increased in
both the HF and HF-FO groups relative to the LF group
(P,0.05), and the HF-FO group exhibited a lower total visceral
adipose tissue mass compared to the HF diet. Biochemical
evidence of an obese phenotype was assessed by monitoring
changes in systemic hormone concentrations (Figure 1C–F).
Compared to LF, the HF group exhibited higher insulin, leptin
and resistin (P,0.05) concentrations whereas adiponectin levels
did not differ (P.0.05). These outcomes are consistent with
previous reports in both rodent HF-diet induced obesity [5,6,12]
and in obese humans [49,50]. Interestingly, the HF-FO group
exhibited an intermediate hormonal phenotype, in which circu-
lating levels of leptin and resistin were significantly reduced
relative to HF (P,0.05) and did not differ from levels observed in
the LF group (P.0.05). HF-FO insulin levels did not differ from
those in the HF or LF groups (P.0.05). Interestingly, serum
adiponectin, an anti-inflammatory hormone typically reduced
during obesity, exhibited a modest but significantly higher
concentration in the HF-FO group relative to both the HF and
LF diets (P.0.05), which is consistent with previous reports with n-
3 PUFA supplementation [5,6,12]. Collectively, these data
confirm the ability of the semi-purified HF diet to recapitulate
critical aspects of the obese phenotype relative to LF. In addition,
n-3 PUFA supplementation to the HF diet mitigated the severity of
the obesity induced changes in the circulating hormone profile and
the accumulation of visceral adipose tissue.
n-3 PUFA Reduce Adipose Tissue Macrophage Infiltration
by Decreasing Both the M1 and M2 Subsets
A hallmark of obesity is the increased infiltration of macro-
phages into the inflamed adipose tissue [51,52,53]. The SVC
population is comprised of multiple cell types including pre-
adipocytes, mesenchymal stem cells, endothelial precursor cells
and immune cells [54], therefore, we initially characterized the
total adipose tissue macrophage population [52]. Representative
dot plots of total, M1 and M2 macrophage subsets are presented in
Figure S1. Consistent with previous reports [51,52,53], there was
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an obesity-associated increase in adipose tissue macrophage
content, i.e., the percentage of F4/80+ CD11b+ cells, which was
increased in the HF group relative to LF (P,0.05, Figure 2A).
Interestingly, compared to HF, the HF-FO diet prevented the
obesity-associated increase in adipose macrophage content,
reducing the percentage of total adipose F4/80+ CD11b+
macrophages by 52% (P,0.05). Further analysis of specific
macrophage subsets (classically activated, M1, and alternatively
activated, M2 subsets, Figures 2B & C, respectively) revealed
that obese mice (HF diet) exhibited a higher percentage of
inflammatory M1 macrophages (F4/80+ CD11c+) compared to
the LF diet (P,0.05). In contrast, the obesity-associated pertur-
bation was prevented by n-3 PUFA supplementation which
reduced the percentage of adipose M1 macrophages compared to
HF by 72% but did not differ from the LF group (P.0.05).
Interestingly, there was no obesity-associated increase in the
percentage of M2 macrophages (F4/80+ CD206+), as the HF and
LF diets did not differ (P.0.05). In the HF-FO group, however,
the percentage of M2 macrophages was also significantly reduced
by 55% in comparison to the HF group. Total macrophage
content in the adipose tissue, therefore, was reduced by n-3 PUFA
without a preference for a particular macrophage subset.
n-3 PUFA Suppress the Obesity-associated Adipose
Tissue Inflammatory Gene Expression Profile
Within the adipose tissue, changes in the local inflammatory
cytokine milieu were assessed at the mRNA level. For all genes
examined, colitis status had no independent effect on adipose
tissue gene expression in any dietary group (i.e., vehicle control
versus TNBS, P.0.05); therefore, the effect of diet alone on
adipose tissue gene expression is presented in Table 1. Consistent
with the ability of n-3 PUFA to reduce the percentage of adipose
tissue infiltrating macrophages during obesity (Figure 2), adipose
mRNA expression of MCP-1, a macrophage chemotactic signal,
was reduced by 44% in the HF-FO group relative to HF alone
(P=0.001). Additionally, compared to HF, n-3 PUFA supple-
mentation reduced the expression of a key inflammatory cytokine,
IL-6 (P=0.008) by 29%. However, gene expression of TNFa and
IL-1b did not differ between dietary groups (P.0.05). Expression
of the classic inflammatory Th1 cytokine, IFNc was down
regulated by 83% in the HF-FO group compared to HF
(P=0.02). Consistent with this finding, expression of the master
transcription factor associated with Th1 cells, Tbet, was also
reduced by n-3 PUFA (P=0.03). Cytokines related to Th17
polarization and maintenance were similarly affected, with mRNA
levels of IL-17F and IL-21 reduced by 65% (P=0.004) and 57%
(P=0.03), respectively, in the HF-FO group compared to HF
Figure 1. Characterization of the diet-induced obese phenotype. C57BL/6 mice were fed a high diet (HF), high fat diet supplemented with
FO (HF-FO) or a low fat (LF) control diet for 12 weeks (n = 12217 TNBS-treated and 4–6 vehicle controls/diet). Mice were presensitized with 1% TNBS
or vehicle control (week 11), followed by a 2.5% TNBS enema or vehicle control (week 12) and sacrificed 3 d post-TNBS. A) Changes in body weight
over time. B) Visceral adipose tissue weight from individual visceral depots (perinephric, mesenteric and epididymal) or combined (total visceral
adipose). Serum concentrations of C) insulin, D) leptin, E) resistin and F) adiponectin. All data were analyzed by two-way ANOVA (main effects: diet
and treatment) and P-values are shown. Bars represent means 6 SEM and statistical significance was (P#0.05). Panel A) asterisk (*) indicates
statistically significant time points where the HF and HF-FO groups differed from LF (P#0.05). Panels B-F) bars not sharing a common letter differ
(P#0.05).
doi:10.1371/journal.pone.0049739.g001
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alone. IL-17A mRNA was undetectable, and there was no
difference between dietary groups in adipose mRNA expression
of IL-23 (P=0.42) and IL-27 (P=0.76). Expression of the
transcription factor that drives the polarization of Th17 cells,
RORct, exhibited a non-significant trend towards suppression by
n-3 PUFA during obesity (HF-FO versus HF, P=0.08). Adipose
expression of the Treg specific transcription factor Foxp3 was
unaffected by diet (P=0.81). Consistent with reduced inflamma-
tory potential, adipose mRNA expression of the anti-inflammatory
cytokine IL-10 was upregulated in the HF-FO group relative to
HF by 42% (P=0.05) whereas expression of TGF-b1 mRNA was
unaffected by diet (P=0.93). Collectively, these data demonstrate
that n-3 PUFA suppress the transcription of inflammatory
cytokines which drive and sustain the local inflammatory
microenvironment within adipose tissue.
HF-FO-fed Mice are more Resistant to TNBS-induced
Colonic Inflammation
The degree of colon inflammation and injury following
exposure to TNBS was assessed based on gross changes observed
within the colon histological architecture in a blinded manner by a
board-certified pathologist (B. Weeks). There was no effect of diet
on vehicle control treated colon histological scores (P=0.11), and
as expected, TNBS treatment increased both colon inflammation
and injury scores, independently of diet (P.0.05) relative to
vehicle controls (data not shown). Representative colon images
from TNBS-treated mice from each dietary group (Figure 3A–C)
and from a representative vehicle control-treated mouse
(Figure 3D) are shown. Within the distal colon of TNBS-treated
mice, there was a significant effect of diet (P=0.05) on the
histological disease score, which was significantly elevated in the
HF group relative to LF (Figure 3E). This outcome is consistent
with previous findings demonstrating that obesity is associated
with a more severe response to TNBS-induced colitis [36].
Interestingly, the HF-FO group exhibited a lower histological
disease score compared to the HF group (P=0.05) but did not
differ from the LF group (P=0.85), indicating that n-3 PUFA
supplementation prevented the obesity-associated enhanced in-
flammatory response to TNBS-induced colitis. These outcomes
are consistent with the ability of dietary n-3 PUFA to enhance the
resolution of inflammatory processes in other colitis models
[25,42].
n-3 PUFA Modulate the Colonic Mucosal Cytokine
Microenvironment in a Manner Consistent with Reduced
Th17 Cell Activation
To gain insight into how effector T cell populations are
changing in the context of concurrent obesity and colitis, the
expression of critical transcription factors associated with specific
T cell subsets in the colonic scraped mucosa, i.e., FOXP3 (Tregs),
Tbet (Th1 cells) and RORct (Th17 cells) and critical cytokines
that influence T cell polarization and function were assessed. For
each gene, colonic mucosal basal (i.e., vehicle control) mRNA
expression did not differ between dietary groups (P.0.05, Table
S2). As expected, exposure to TNBS upregulated mucosal gene
expression relative to vehicle controls (P,0.05) in all dietary
groups; therefore, the outcomes between dietary groups among
TNBS-treated mice only are shown in Table 2. During TNBS-
induced colitis, there was an obesity-associated 43% increase in
Figure 2. Visceral adipose tissue macrophage infiltration. Stromal vascular cells (SVC) were isolated and quantified from total visceral adipose
tissue (HF and HF-FO groups, n = 3 vehicle controls and 6–8 TNBS-treated mice, LF n = 4 pooled samples comprised of 3–4 mice/treatment). A)
percentage of F4/80+ CD11b+ cells (total macrophages), B) percentage of F4/80+ CD11c+ cells (M1 macrophages), C) percentage of F4/80+ CD206+
cells (M2 macrophages). Data were analyzed by two-way ANOVA (main effects: diet and treatment) and bars represent mean values 6 SEM. Bars not
sharing a common letter are significantly different (P#0.05).
doi:10.1371/journal.pone.0049739.g002
Table 1. Visceral adipose tissue mRNA expression1.
Gene HF HF-FO LF Diet: P-value
MCP-1 5.0160.49a 2.8260.3b 1.9160.61b 0.001
TNFa 11.0061.28 7.8160.63 8.8664.01 0.10
IFNc 11.9764.23a 2.0960.74b 4.8162.78ab 0.02
IL-1b 2.0260.51 2.2260.46 1.3960.38 0.91
IL-6 1.3360.41a 0.9460.33b 2.2960.38b 0.008
IL-10 4.1760.35a 7.1461.55b 5.3463.03a 0.05
IL-17F 1.0360.32a 0.3660.15b 1.7261.21ab 0.004
IL-21 11.4262.95a 4.9561.31b 0.9560.12b 0.03
IL-23 10.1361.48 7.6061.3 9.7561.51 0.42
IL-27 8.3561.02 9.5361.15 9.0962.47 0.76
TGF-b1 8.8160.85 8.2960.93 8.6261.73 0.93
RORct 9.0863.21 3.7560.54 3.2960.94 0.08
T-bet 6.5861.06a 3.9360.53b 3.9260.50b 0.03
Foxp3 1.6260.41 1.0660.22 1.2660.54 0.81
1Values are means 6 SEM (n = 5210/dietary group). Data were analyzed by
two-way ANOVA (main effects: diet and treatment). For all genes, there was no
effect of treatment (i.e., TNBS versus vehicle, P.0.05), therefore, only the main
effect of diet is shown. Within individual genes, values not sharing a lower case
letter denote significant differences (P#0.05). Data were normalized to
ribosomal 18S.
doi:10.1371/journal.pone.0049739.t001
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mucosal expression of RORct mRNA (LF versus HF, P=0.03).
Interestingly, supplementation of n-3 PUFA blocked the obesity-
associated increase in RORct expression, which was significantly
reduced compared to the HF group but did not differ from LF.
These data demonstrate that expression of RORct, a master
transcription factor that directs both the differentiation of Th17
cells and the expression of hallmark Th17 cytokines [55], was
modulated by n-3 PUFA in a manner consistent with a reduced
Th17 cell response in the colon. Tbet, the master transcription
factor driving Th1 cell polarization, similarly exhibited an obesity-
associated elevation in mucosal mRNA expression during TNBS-
induced colitis (HF vs. LF, P=0.02). However, Tbet mRNA
Figure 3. Colon histological disease scores for TNBS-treated mice. Colonic mucosal injury (0–3) and inflammation (0–3) scores were assessed
in a blinded manner by a board-certified pathologist (B. Weeks) and combined for a total score (0–6). Representative images (1006magnification)
are shown for the HF, HF-FO and LF TNBS-treated groups, respectively (panels A-C) and a representative image of a HF vehicle control (panel D) is
shown. E) Combined injury/inflammation histological score within the distal colon (n = 10214 TNBS treated mice/diet). Data were analyzed using the
Kruskal-Wallis test followed by Wilcoxon two-sample testing, and bars represent median values. Bars not sharing a common letter are significantly
different (P#0.05).
doi:10.1371/journal.pone.0049739.g003
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expression in the HF-FO group did not differ from either HF or
LF (P.0.05), but exhibited an intermediate level of expression
with a trend towards suppression by n-3 PUFA (HF versus HF-
FO, P=0.07). There was no effect of diet on FOXP3 mRNA
expression (P.0.05).
Expression of colonic lamina propria cell-derived cytokines
known to govern Th17 cell differentiation/polarization, prolifer-
ation and maintenance of a Th17 cell phenotype were also
examined (Table 2). As expected, exposure to TNBS upregulated
mucosal inflammatory gene expression relative to vehicle controls
(P.0.05) in all dietary groups. Within TNBS-treated mice, the
HF-FO diet reduced mucosal mRNA expression of Th17
cytokines, IL-17A and IL-17F, by 64% (P=0.05) and 66%
(P=0.01), respectively, compared to HF. Similarly, HF-FO
reduced IFNc mRNA expression by 80% (P=0.05) compared to
HF. Additionally, dietary n-3 PUFA reduced IL-6 and IL-21
mRNA expression by 83% (P=0.03) and 75% (P=0.03),
respectively, compared to HF. This is noteworthy because in
combination with TGF-b, which was unaffected by diet (P=0.54),
IL-6 or IL-21 can drive Th17 cell differentiation [56]. Similarly,
mucosal mRNA expression of IL-23, which contributes to Th17
cell expansion, stabilization and/or conditioning of a fully
inflammatory cell phenotype [57], was reduced by 43%
(P=0.04) in HF-FO-fed mice relative to HF whereas mRNA
expression of IL-1b and IL-27 were unaffected by diet (P.0.05).
Conversely, consistent with the anti-inflammatory nature of n-3
PUFA, mucosal mRNA expression of IL-10 was elevated 67%
(P=0.03) in the HF-FO group versus HF. Collectively, these data
indicate that during coincident obesity and TNBS-induced colitis,
the inflammatory phenotype of the colonic mucosal cytokine
microenvironment is suppressed by n-3 PUFA.
n-3 PUFA Suppress Systemic Inflammatory Th17 and Th1
Cells Following TNBS Exposure
Critical T cell subsets were monitored in the spleen, the central
systemic lymphoid organ of the body that is responsible for
propagating inflammatory immune responses following colitis
induction, and representative dot plots for each T cell subset are
shown in Figure S2. The percentage of splenic Tregs (CD4+
FOXP3+, Figure 4A) did not differ between dietary groups
(P=0.64) nor did this subset of cells exhibit a colitis-associated
change in frequency (P=0.45). Conversely, the percentage of
splenic Th17 cells (CD4+ IL-17A+, Figure 4B) was elevated
within both the HF and LF diet groups following the induction of
colitis (within dietary groups vehicle control versus TNBS,
P,0.05), which was not apparent in the HF-FO group (vehicle
control versus TNBS-treated, P=0.66). Moreover, the magnitude
of the TNBS-associated induction in splenic Th17 cells was higher
in the HF group relative to the LF, indicating that obesity
promoted a colitis-associated Th17 cell response, as reported
previously [36]. Within TNBS-treated mice, the HF-FO group
exhibited a reduced percentage of Th17 cells relative to HF but
did not differ from LF. Similarly, the percentage of inflammatory
Th1 cells (CD4+ IFNc+, Figure 4C) exhibited a TNBS-associated
increase compared to vehicle controls in the HF and LF groups;
however, this was prevented in the HF-FO group. Although the
magnitude of the colitis-associated change in Th1 cells did not
differ between the HF and LF groups, comparatively, HF-FO
reduced the percentage of Th1 cells (P,0.05). Overall, these data
indicate that n-3 PUFA suppress the systemic induction of two
critical inflammatory T cell subsets that are strongly implicated in
the pathogenesis of IBD [20].
One potential mechanism underlying the observation of
reduced splenic Th17 cells in the HF-FO group is the ability of
n-3 PUFA to suppress T cell differentiation into a Th17 cell
phenotype. To address this mechanism, splenic CD4+ T cells were
purified from TNBS-treated mice and cultured under Treg and
Th17 cell polarizing conditions ex vivo (Figures 5A & B). Clonal
expansion of Treg cells was unaffected by diet (P=0.17).
Conversely, differentiation of CD4+ T cells into Th17 cells was
altered by diet (P=0.04), with an increased percentage of Th17
cells detected in the HF group versus LF. Moreover, Th17 cell
polarization was reduced in the HF-FO group as compared to HF
(P,0.05).
Discussion
We examined the effects of n-3 PUFA supplementation on
obesity-associated colitis severity using the TNBS model of
chemically induced colitis which is considered to be representative
of CD [48]. Since the low-grade chronic inflammation associated
with obesity further complicates many disease states, elucidation of
mechanisms through which dietary n-3 PUFA impact the clinical
outcome of concurrent diet-induced obesity and colitis has
translational utility. In the TNBS colitis model, obesity increases
disease severity and exhibits a bias towards the activation of
inflammatory Th17 cells [36], a T cell subset that plays a
pathogenic role in IBD [18,57]. Moreover, obesity worsens the
clinical outcome of CD wherein adipose-derived inflammatory
mediators perpetuate inflammatory responses [26,32,33], promot-
ing a more aggressive clinical course [27,31,34,35]. Focusing on
three major tissue sites, namely the visceral adipose tissue (local site
of obesity-associated inflammation and a major endocrine organ
that is closely associated with the inflamed colon during colitis),
colon (target tissue and site of local inflammation in colitis) and
spleen (indicative of the systemic immunological and inflammatory
phenotype), we were able to document changes in both the local
and systemic inflammatory milieu while tracking changes in key
immune cell populations driving the obesity-associated inflamma-
tory response to colitis.
Table 2. Colonic mucosal mRNA expression in TNBS-treated
mice1.
Gene HF HF-FO LF P-value
RORct 2.360.3a 1.660.1b 1.360.2b 0.03
T-bet 3.661.9 2.160.2 1.160.4 0.07
Foxp3 2.860.7 2.160.4 1.260.5 0.18
IL-6 12.863.6a 2.260.7b 6.860.3ab 0.03
IL-1b 18.368.9 3.361.6 11.366.2 0.29
IL-17A 15.464.5a 5.562.1b 4.262.4b 0.05
IL-17F 4.461.0a 1.560.4b 2.860.4ab 0.01
IL-21 3.260.5a 0.860.2b 3.460.7a 0.03
IL-23 9.562.5a 5.460.8b 8.960.6a 0.04
IL-27 6.561.5 5.060.7 5.260.8 0.60
IFNc 6.562.4a 1.360.2b 5.961.4a 0.05
IL-10 0.660.3a 1.860.4b 0.360.07a 0.03
TGF-b1 3.560.6 3.060.8 3.760.9 0.54
1Values are means 6 SEM (n = 6/TNBS-treated mice/dietary group). Data were
analyzed by two-way ANOVA (main effects: diet and treatment). For all genes,
only the effect of diet is shown (P#0.05). Values not sharing a lower case letter
differ. Data were normalized to ribosomal 18S.
doi:10.1371/journal.pone.0049739.t002
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The HF-FO diet significantly impacted the obese phenotype in
a manner consistent with reduced inflammation and improved
metabolic outcomes. The blood hormone profile was improved as
dietary n-3 PUFA reduced circulating levels of the inflammatory
hormones leptin and resistin (Figure 1C & D), while increasing
the levels of the anti-inflammatory hormone adiponectin relative
to the HF group (Figure 1E). These results confirm previous
findings in n-3 PUFA supplemented rodent diet-induced obesity
models [5,6,12] and extend the n-3 PUFA modifiable blood
hormone profile to include resistin, an inflammatory adipokine
that is increased in both the serum and adipose tissue in obese
humans [49,58].
Obesity-induced adipose tissue inflammation is a unique process
characterized by a broad panel of cytokines [37,59]. The obesity-
related adipose gene expression pattern was dramatically altered
by the HF-FO diet (Table 1), whereby expression of MCP-1, IL-6
and IFNc mRNA levels were reduced and IL-10 mRNA
expression was elevated, compared to HF. Moreover, mRNA
levels of cytokines related to the inflammatory Th17 cell
population, IL-17F and IL-21, were also reduced by n-3 PUFA.
Lastly, mRNA expression of adipose derived T cell-associated
transcription factors specific for particular inflammatory T cell
subsets Tbet (Th1 cells) and RORct (Th17 cells) were significantly
reduced or exhibited a non-significant trend towards reduction,
respectively, by n-3 PUFA.
A hallmark of obesity is the increased infiltration of macro-
phages into the inflamed adipose tissue [51,52,53]. Interestingly,
n-3 PUFA reduced the percentage of adipose tissue macrophages
(F4/80+ CD11b+) relative to the HF diet (Figure 2A), consistent
with the effect of n-3 PUFA on reducing MCP-1 gene expression
(Table 1). Macrophages are broadly characterized as M1 or M2
by their polarization or activation state [60]. The M1 designation
denotes classically activated macrophages (i.e., following stimula-
tion with IFNc and LPS), which exhibit an inflammatory
phenotype (secrete high levels of TNFa, IL-6, IL-1b and MCP-
1) and gene expression profile that differs from alternatively
activated M2 macrophages which exhibit an anti-inflammatory
phenotype and support tissue repair, remodeling and inflamma-
tion resolution via secretion of components of the extracellular
matrix and IL-10 [44,45,53,61]. In obesity, adipose tissue
macrophages seemingly undergo a phenotypic switch from the
M2 to the M1 phenotype [51,52]. However, the precise
mechanism underlying this observation is unknown and could be
a result of newly recruited M1 macrophages to the adipose from
the circulation, differentiation of resident M2 macrophages into
the M1 phenotype, or both. Interestingly, our data indicate that
the obesity-associated increase in adipose M1 macrophages can be
prevented by the HF-FO diet (Figure 2B). There was no obesity-
associated change in the percentage of adipose M2 macrophages
(HF vs. LF); however, the percentage of M2 cells in the HF-FO
group was significantly reduced relative to both HF and LF
(P=0.011, Figure 2C). Collectively, these results demonstrate
that supplementation of n-3 PUFA to a high fat diet reduces total
adipose macrophage infiltration, thereby reducing the percentage
of both the M1 and M2 subsets. The reduction in M1 macrophage
number, a predominant cellular source of inflammatory adipo-
kines [44,45,51,61], may explain the reduced mRNA levels of IL-6
and MCP-1 in the HF-FO group. Overall, the HF-FO diet
Figure 4. Effect of diet and colitis on splenic T cell subsets. A) Tregs (CD4+ FOXP3+), B) Th17 (CD4+ IL17A+), and C) Th1 (CD4+ IFNc+) cell
populations (n = 3–6 vehicle controls and n=6212 TNBS treated mice/dietary group). Bars represent mean values6 SEM. Bars not sharing a common
letter are significantly different (P#0.05).
doi:10.1371/journal.pone.0049739.g004
Figure 5. Effect of diet on splenic CD4+ T cell polarization. Splenic CD4+ cells were purified by positive selection and cultured for 3 d under A)
Th17 or B) Treg polarizing conditions (see Materials and Methods, n = 324 TNBS treated mice/dietary group). Bars represent mean values6 SEM. Bars
not sharing a common letter are significantly different (P#0.05).
doi:10.1371/journal.pone.0049739.g005
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dramatically ameliorated the adipose tissue inflammatory pheno-
type; including reducing (i) circulating levels of adipocyte derived
inflammatory hormones (leptin and resistin), (ii) adipose inflam-
matory cytokine mRNA expression and (iii) total macrophage
infiltration and the percentage of inflammatory M1 cells.
Obesity increases the severity of mucosal damage associated
with TNBS-induced colitis [36], and we confirmed this finding by
observing that colon injury and inflammation scores were higher
in the HF group compared to LF. A key novel finding of this study
was the ability n-3 PUFA supplementation to ameliorate the
obesity-associated increase in colon architectural damage
(P=0.05, Figure 3E). This beneficial effect of n-3 PUFA has
been observed previously in the chronic DSS colitis model [25]
and is consistent with the ability of dietary n-3 PUFA to promote
long-term resolution of colon inflammation and mucosal repair
[42,62]. Furthermore, we monitored the inflammatory milieu
based on changes in gene expression within the colonic mucosal
microenvironment with a particular focus on Th17 cell-related
cytokine targets, as the combination of obesity and TNBS-induced
colitis is associated with a bias towards Th17 cells [36]. In TNBS-
treated mice, the obesity-associated increase in colonic mRNA
levels of Th17-associated cytokines was suppressed by n-3 PUFA
(Table 2). Thus, colonic mucosal mRNA expression of IL-17A,
IL-17F, IL-6, IL-21, IL-23 and INFc was reduced in the HF-FO
group compared to HF. Consistent with the reduced activation
and presence of inflammatory T cell subsets within the colon
following colitis induction, mRNA expression of the Th17 cell
specific transcription factor RORct was significantly reduced by
n-3 PUFA, whereas Tbet mRNA levels showed a non-significant
trend towards suppressed colonic expression. Therefore, on an
mRNA level, signature cytokines of inflammatory T cell subsets
involved in the pathogenesis of colitis [18,20] are significantly
reduced by dietary n-3 PUFA. Lastly, n-3 PUFA upregulated
mRNA expression of the anti-inflammatory cytokine, IL-10, which
suppresses colonic inflammation [63] and is capable of suppressing
Th17 cells [64,65]. These findings confirm previous reports that n-
3 PUFA suppress multiple aspects of Th17 cell mucosal biology
during chronic colitis [25] and collectively demonstrate that n-3
PUFA modulate the colonic cytokine microenvironment in a
manner that is less compatible with the activation, polarization,
proliferation, maintenance and function of pathogenic inflamma-
tory Th17 cells [18,25,56].
We demonstrate for the first time that the combined obesity and
colitis-associated increase in the percentage of inflammatory
splenic Th17 and Th1 cells is reduced by n-3 PUFA
(Figure 4B&C). These data provide direct evidence that dietary
n-3 PUFA can prevent the obesity-associated Th17 cell bias.
When splenic CD4+ T cells were cultured under Th17 cell
polarizing conditions (Figure 5A), n-3 PUFA rendered the cells
more refractive towards polarization signals. Further studies are
required to determine the mechanism(s) by which n-3 PUFA
suppress Th17 polarization.
In summary, we combined established models of high fat diet
induced obesity and colitis to demonstrate the ability of dietary
long chain n-3 PUFA to ameliorate disease progression, in part, by
reducing inflammatory cytokine gene expression and immune cell
populations both locally and systemically. The obesity-associated
bias towards inflammatory Th17 cells was prevented by n-3 PUFA
supplementation. Both the adipose and colonic mucosal gene
expression profiles were reconfigured in a manner consistent with
reduced inflammatory capacity and the suppression of Th17 cell
activation and function. Further studies are required to determine
the utility of dietary n-3 PUFA as an anti-IL-17 and/or anti-IFNc
therapy for treating chronic inflammatory diseases.
Supporting Information
Figure S1 Representative dot plots from high fat (HF) TNBS-
treated mouse visceral adipose tissue stromal vascular cells. A)
Total macrophages (F4/80+ CD11b+), B) M1 macrophages (F4/
80+ CD11c+), and C) M2 macrophages (F4/80+ CD206+).
(TIF)
Figure S2 Representative dot plots of splenic T cell subsets
isolated from high fat (HF) TNBS-treated mice. T cell subsets were
identified within a mononuclear cells suspension by a combination
of surface (CD4+) and intracellular staining. A) Tregs (CD4+
FOXP3+), B) Th17 cells (CD4+ IL17A+) C) Th1 cells (CD4+
IFNc+). CD4+ T cells were purified by positive selection (Miltenyi
Biotec) and cultured for 72 h under Treg or Th17 cell polarizing
conditions (see Materials and Methods). Representative dot plots
of polarized D) Tregs (CD4+ FOXP3+) and E) Th17 cells (CD4+
IL17A+) are shown.
(TIF)
Table S1 Semi-purified diet composition. All diet constituents
were purchased from Bio Serv (Bio Serv, Frenchtown, NJ), except
lard (ConAgra Foods, Omaha, NE) corn oil (Dyets, Madison, WI)
and fish oil (Omega Protein Inc, Reedville, VA).
(PDF)
Table S2 Colonic mucosal mRNA expression in vehicle control
treated mice. Values are means 6 SEM (n= 426/vehicle control
mice/dietary group). Data were normalized to ribosomal 18S and
analyzed by ANOVA. For all genes, the effect of diet is shown
(significance P#0.05).
(PDF)
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